3,4beta-dihydrosamaderine C - Compound Card

3,4beta-dihydrosamaderine C

Select a section from the left sidebar

3,4beta-dihydrosamaderine C

Structure
Zoomed Structure
  • Family: Plantae - Simaroubaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Triterpene Lactone
Canonical Smiles C[C@@H]1C[C@@H](O)[C@H]([C@]2([C@H]1CC(=O)[C@@]13[C@@H]2[C@@H](O)[C@H]2[C@]([C@@H]3C(=O)O2)(OC1)C)C)O
InChI InChI=1S/C19H26O7/c1-7-4-9(20)14(23)17(2)8(7)5-10(21)19-6-25-18(3)13(19)16(24)26-15(18)11(22)12(17)19/h7-9,11-15,20,22-23H,4-6H2,1-3H3/t7-,8+,9-,11-,12-,13+,14-,15+,17+,18+,19-/m1/s1
InChIKey YYTLZLJYNQJRGD-XJQYOZBDSA-N
Formula C19H26O7
HBA 7
HBD 3
MW 366.41
Rotatable Bonds 0
TPSA 113.29
LogP -0.35
Number Rings 5
Number Aromatic Rings 0
Heavy Atom Count 26
Formal Charge 0
Fraction CSP3 0.89
Exact Mass 366.17
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Samadera madagascariensis Simaroubaceae Plantae 459147

Showing of synonyms

  • Coombes PH, Naidoo D, et al. (2005). Quassinoids from the leaves of the Madagascan Simaroubaceae Samadera madagascariensis. Phytochemistry, 2005, 66(23), 2734–2739. [View]
Pubchem: 21574501
Nmrshiftdb2: 70025056

No compound-protein relationship available.

Structure

SMILES: C123C4C(OC1)C(OC4=O)CC3C5C(CC2=O)CCCC5

Level: 0

Mol. Weight: 366.41 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-4.79
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.82
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Substrate
Skin Permeability
-1.99

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.38
Plasma Protein Binding
62.58
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
3.33
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-2.42
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-0.28
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
5.06
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-5.31
Rat (Acute)
3.92
Rat (Chronic Oral)
2.59
Fathead Minnow
3.61
Respiratory Disease
Safe
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
425.83
Hydration Free Energy
-8.22
Log(D) at pH=7.4
0.72
Log(P)
0.56
Log S
-2.13
Log(Vapor Pressure)
-9.95
Melting Point
221.64
pKa Acid
5.95
pKa Basic
4.33
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Nuclear receptor subfamily 1 group I member 2 O75469 NR1I2_HUMAN Homo sapiens 3 0.7714
Adenylate cyclase type 5 P30803 ADCY5_CANLF Canis lupus familiaris 3 0.7515

Download SDF